Eiger BioPharmaceuticals Q3 EPS $(0.76) Misses $(0.75) Estimate

Eiger BioPharmaceuticals (NASDAQ:EIGR) reported quarterly losses of $(0.76) per share which missed the analyst consensus estimate of $(0.75) by 1.33 percent. This is a 36.67 percent increase over losses of $(1.2) per

Benzinga · 11/07/2019 21:46

Eiger BioPharmaceuticals (NASDAQ:EIGR) reported quarterly losses of $(0.76) per share which missed the analyst consensus estimate of $(0.75) by 1.33 percent. This is a 36.67 percent increase over losses of $(1.2) per share from the same period last year.